Mohanad Yaman

1 cent. That's what wiped about 31% off $ATEC premarket 📉😨 EPS $0.09 vs $0.10 expected Sales $221M vs $225M expected 2026 sales guide cut to $862M Surgery cases still grew 20%. Overreaction? 🤔

$LOW base breakout 👀 Lowe's, the US home improvement retailer selling to DIY and pro customers. 🔹 Ranged between $194.43 and $204.52 for 9 sessions (Oct 16 to Oct 28) 🔹 Yesterday it closed at $207.28, up 4.5%, over the top of the base at $204.52 📊 Q2 sales $26.0B (up 8.3%), comps up 0.2% for a 5th straight positive quarter, adjusted EPS $4.40 (up 1.6%, includes a $0.11 tariff refund benefit) 💰 2026 guide: sales about $92.0B, flat comps, adjusted EPS about $12.25, all at the low end of the prior ranges 📈 Pro, online (up 15.7%) and home services are carrying it while DIY spending stays soft ⚠️ Results come Nov 18 before the open, with the Street near $2.80 to $2.86 EPS vs $3.06 a year ago. Stifel cut its target from $220 to $195 on Oct 26 and kept a Hold ✅ Confirmed: daily close over $204.52 🟢 TP1 $221.67 (+8.4%) • TP2 $239.17 (+16.9%) • TP3 $254.04 (+24.2%) ⛔ Invalid: daily close under $201.45 (down 1.5%) Risk from the $207.28 close to Invalid is about 2.8%, and TP1 pays about 2.5x. Please respect your SL level 🙏

$IDCC descending triangle breakout 👀 InterDigital, licensor of the wireless, video and AI patents inside phones, PCs and streaming services. 🔹 Three lower highs at $355.69 (Sep 11), $346.80 (Oct 2) and $335.80 (Oct 21), with a flat base at $314.68 (Oct 15 low) 🔹 Yesterday it closed at $334.27, up 4.3% on earnings, over the falling line at $331.68 📊 Q3 revenue $193.4M (up 17%) vs its own guide of $154M to $158M, non-GAAP EPS $3.11 (up 22%) vs a guide of $1.94 to $2.13, record annualized recurring revenue of $629M 💰 2026 guide raised: revenue $813M to $819M, non-GAAP EPS $11.99 to $12.25, based only on contracts already signed 📈 New PC license through arbitration, 4 of the top 5 PC makers now licensed, dividend raised from $0.70 to $0.75 ⚠️ Results are already out, so this is the post earnings move. $36.2M of Q3 revenue was one time catch up and smartphone revenue fell 10%. The close is only $2.59 over the confirm, and TP1 sits on the $355.69 September high. Next results expected around Feb 18 ✅ Confirmed: daily close over $331.68 🟢 TP1 $355.69 (+7.2%) • TP2 $383.13 (+15.5%) • TP3 $421.23 (+27.0%) ⛔ Invalid: daily close under $326.70 (down 1.5%) Risk from the $334.27 close to Invalid is about 2.3%, and TP1 pays about 2.8x. Please respect your SL level 🙏

$ADMA base breakout 👀 ADMA, maker of plasma derived immune globulin drugs for people with weak immune systems. 🔹 Stuck under the $11.42 April high (Apr 24) for six months 🔹 Yesterday it closed at $11.75, up 4.2%, over that level at $11.42 📊 Q2 revenue $124.4M (up 2%), ASCENIV revenue $102.9M (up 24%), GAAP net income $37.8M (up 11%) 💰 2026 guide: revenue $530M to $560M, adjusted EBITDA $265M to $300M, reiterated in August 📈 ASCENIV is the growth driver, BIVIGAM demand is stabilizing after a 49% drop, and the company is buying back $200M or more of stock this year ⚠️ Results come Nov 4 after the close, with the Street at $0.20 EPS on $138M of revenue. That's about 11% above Q2 revenue, and it missed revenue estimates in both Q1 and Q2 ✅ Confirmed: daily close over $11.42 🟢 TP1 $14.32 (+25.4%) • TP2 $16.39 (+43.5%) • TP3 $18.00 (+57.6%) ⛔ Invalid: daily close under $10.88 (down 4.7%) Risk from the $11.75 close to Invalid is about 7.4%, and TP1 pays about 3.0x. Please respect your SL level 🙏

Halloween came early this year 🎃 $RBLX down 16% premarket. Sales beat at $1.57B, but daily users 138M vs 146M expected $TWLO down 20% premarket. EPS $1.65 beat, but Q4 growth guide slows to 11% to 12% $ILMN down 14% premarket. EPS $1.44 beat, but sales $1.13B missed $1.15B Beat earnings and still got spooked 👻

Answer: $REGN 💊 $REGN beat big. EPS $20.07 vs $16.07 est. Up 6.8% premarket. $ABBV beat too and raised its 2026 guide, but it's down 2.9% premarket. Both beat, so why is only one going up?

$XOM and $CVX both beat this morning 🛢️ $CVX: EPS $5.28 vs $4.89 est. Sales $67.8B vs $61.6B. $XOM: EPS $4.23 vs $4.08 est. Sales $113.2B vs $103.1B. High diesel prices did the work. Both ran their US refineries near full. $XOM up 1.6% premarket, $CVX up 1.3%.

$RDDT down about 21% before the bell 📉 Sales jumped 53% to $895M and still the stock sank The CEO says $GOOGL search sent over 1 million fewer visits a week in October Now Reddit plans to make everyone log in to read Is $GOOGL's AI search eating the open web? 🤔

Intel is up 159% this year. Amazon is up 10% 👀 Both report tonight after the close 🚨 $INTC 🔹 Up 159% in 2026 🔹 But down 25% from its Sep 24 high 🔹 Still 33% below its $142.35 all time high $AMZN 🔹 Up 10% in 2026 🔹 11.4% below its $287.20 all time high 🔹 Expected to bring in about $202B in one quarter One is the comeback story of 2026, cooling off fast. One is the giant nobody is excited about. Which one surprises tonight? 👇

$INTC reports tonight after the close 💻 How it moved the day after its last 4 reports: 🟢 Oct 2025: up 0.3% 🔴 Jan 2026: down 17.0% 🟢 Apr 2026: up 23.6% 🔴 Jul 2026: down 7.9% 2 green, 2 red. Two moves over 17%. In 2026 it's up 150%, way over the S&P 500's 12.7%. Intel's own guide for this quarter: $15.8B to $16.8B in sales. Big move again, or a quiet one? 👇

$SNDK reports tonight after the close 💾 How it moved the day after its last 4 reports: 🟢 Nov 2025: up 15.3% 🟢 Jan 2026: up 6.9% 🟢 May 2026: up 8.3% 🔴 Aug 2026: down 6.8% 3 green, 1 red. Every move over 6%. In 2026 it's up 470%, way over the S&P 500's 12.7%. SanDisk's own guide for this quarter: $10.3B to $10.8B in sales. Big move again, or a quiet one? 👇

$AMZN reports tonight after the close 📦 👀 How it moved the day after its last 4 reports: 🟢 Oct 2025: up 9.6% 🔴 Feb 2026: down 5.6% 🟢 Apr 2026: up 0.8% 🟢 Jul 2026: up 15.3% 3 green, 1 red. Two moves over 9%. In 2026 it's up just 9.7%, under the S&P 500's 12.9%. Amazon's own guide for this quarter: $197B to $202B in sales. Big move again, or a quiet one? 👇

Is this a dead $CAT bounce or is it really back?? 🔥

I HOPE YOU GUYS DIDNT LISTEN TO ME 🫠

Wait. I thought biosciences were safe investments! What happened? $IOVA down 32% premarket at $9.99 They released new lung cancer data this morning: • Overall response stayed at about 25%. No improvement • Patients with the common KRAS mutation: only 11% • One small group of smokers: 59% So the drug works, but only for a much smaller group of patients. Smaller market, lower price. Biotech is never safe. One data release can cut a third off the stock.

Fortinet beat on sales and profit last night. The stock fell 25.7% after hours 🤯 Here's what $FTNT reported: 🔹 Revenue $2.08B vs $2.06B expected, up 20% 🔹 EPS $0.91 vs $0.86 expected 🔹 Billings up 29% to $2.34B 🔹 Raised its full year guide The miss? Gross margin came in at 79.6% vs 80.1% expected. Half a point. Service revenue also grew just 13%, while product revenue jumped 37%. 📉 Closed Wednesday at $174.08, then $129.33 after hours 💸 That's about $33B of value gone in one evening 🚀 It went into the report up 119% in 2026 When a stock doubles, even a small crack gets punished. Buy the dip on $FTNT, or wait for the dust to settle? 👇

$LLY makes it 5 for 5 💊 🔥🔥🔥🔥🔥 🔹 Revenue $24.4B vs $22.6B expected, up 39% 🔹 EPS $7.48 vs $6.26 expected 🔹 Mounjaro $10.7B, up 65% 🔹 Zepbound $5.35B, up 49% 🔹 Full year guide raised to $91B to $92B, from $85B to $87B The only soft spot: the Foundayo pill did $184M vs about $229M expected. Stock up about 3.9% premarket. The streak lives on 🔥

$CAT beat again, but this time the stock is red 🚜 🔹 EPS $7.20 vs about $7.10 expected, up from $4.95 a year ago 🔹 Sales $20.7B, up 17% 🔹 Operating margin 20.4%, up from 17.3% 🔹 Record backlog and strong orders The stock is down about 7% premarket. That's 5 beats in a row, and the first time in this run that a beat isn't getting a green day: 🔹 Oct 2025: up 11.6% 🔹 Jan 2026: up 3.4% 🔹 Apr 2026: up 9.9% 🔹 Aug 2026: up 5.6% 🔹 Today: down about 7% premarket When a stock is up 24.5% this year, beating isn't enough anymore. Buy the dip or wait? 👇

$SG bull flag breakout 👀 Sweetgreen, the fast casual rip salad @HunterAllen4 and bowl chain 🔹 Ran from $6.61 on Sep 16 to $10.64 on Oct 15 🔹 Then 9 days of rest between $9.54 and $10.77 🔹 Yesterday it jumped 9.0% and closed at $11.24, over the flag top and over its $10.63 May high 🔹 Volume about 1.37x its 20 day average 🔹 Over the 20 day, 50 day and 200 day averages ⚠️ Earnings come Nov 5 after the close. That's a big risk, price can jump or drop hard on the report ✅ Confirmed: daily close over $10.77 🟢 TP1 $13.06 (+21.3%) • TP2 $14.48 (+34.4%) • TP3 $16.76 (+55.6%) ⛔ Invalid: daily close under $10.20 (5.3% under confirm) Risk from the $11.24 close to Invalid is about 9.3%, and TP1 pays about 1.75x. Please respect your SL level 🙏

$GEHC double bottom breakout 👀 GE HealthCare, the scanners, imaging machines and patient monitors used in hospitals. 🔹 Two lows near the same level: $62.99 on Sep 17 and $63.31 on Oct 8 🔹 Yesterday it jumped 6.6% on earnings and closed at $75.82, over the $75.65 August high 🔹 Volume about 2.8x its 20 day average 🔹 Back over the 20 day, 50 day and 200 day averages 📊 It raised its full year guide to $4.95 to $5.05 a share ⚠️ Still about 15.5% under its $89.77 January high, so there's room, but also old sellers up there ✅ Confirmed: daily close over $75.65 🟢 TP1 $82.93 (+9.6%) • TP2 $89.77 (+18.7%) • TP3 $94.64 (+25.1%) ⛔ Invalid: daily close under $71.88 (5.0% under confirm) Risk from the $75.82 close to Invalid is about 5.2%, and TP1 pays about 1.8x. Please respect your SL level 🙏